PET/CT Response Predicts Histopathologic Response after Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer - Chuong, M.D.; Hoffe, S.E.; Shridhar, R.; Almhanna, K.; Weber, J.; Centeno, B.A.; Leon, M.E.; Springett, G.M.; Hodul, P.J.; Malafa, M.P. (International Journal of Radiation Oncology, Biology, Physics, 2011)